Celiac Disease and Quality of Life in Children and Adolescents (CeliaQLife)
Launched by OSLO UNIVERSITY HOSPITAL · Aug 20, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Celiac Disease and Quality of Life in Children and Adolescents" (CeliaQLife) is studying how celiac disease affects the nutritional health and overall quality of life in children and teens. Celiac disease is a condition where the body reacts negatively to gluten, a protein found in wheat, barley, and rye. The only effective treatment is a strict gluten-free diet, which can impact both physical health and emotional well-being. This study aims to compare the nutritional status of children with celiac disease to that of healthy children by looking at their eating habits, body composition, and overall quality of life.
Children aged between 2 to 18 years who are currently eating a regular diet may be eligible to participate in this study. Participants will undergo assessments to evaluate their nutrition and quality of life. By joining, families can help researchers gain valuable insights that could improve the health and well-being of children living with celiac disease. If you have questions or want to know more about the study, feel free to ask!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • eating a regular diet
- Exclusion Criteria:
- • -
About Oslo University Hospital
Oslo University Hospital is a leading academic medical center in Norway, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes the development of new therapies and treatment strategies. With a multidisciplinary approach, Oslo University Hospital collaborates with various stakeholders, including researchers, healthcare professionals, and industry partners, to enhance clinical outcomes and contribute to the global medical community. Its dedication to ethical standards and patient safety ensures that all trials are conducted with the highest level of integrity and respect for participant welfare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, , Norway
Oslo, , Norway
Patients applied
Trial Officials
Janne A Kvammen, Phd
Principal Investigator
Oslo University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported